Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Cavion
Cavion
As investors fret about Xyrem durability, Jazz spends $52M+ upfront to swallow neuro-focused biotech
Endpoints
Wed, 08/14/19 - 10:19 am
Jazz Pharma
Xyrem
Cavion
M&A